Rivera Paulina, Ocaranza María Paz, Lavandero Sergio, Jalil Jorge E
Department of Cardiovascular Diseases, Medical School, P. Universidad Católica de Chile, Santiago, Chile.
Hypertension. 2007 Oct;50(4):792-8. doi: 10.1161/HYPERTENSIONAHA.107.095117. Epub 2007 Sep 4.
The RhoA/Rho kinase (ROCK) pathway is a new mechanism of remodeling and vasoconstriction. Few data are available regarding ROCK activation when angiotensin I-converting enzyme is high and blood pressure is normal. We hypothesized that ROCK is activated in the vascular wall in normotensive rats with genetically high angiotensin I-converting enzyme levels, and it causes increased vascular expression of genes promoting vascular remodeling and also oxidative stress. Aortic ROCK activation, mRNA and protein levels (of monocyte chemoattractant protein-1, transforming growth factor [TGF]-beta(1), and plasminogen activator inhibitor-1 [PAI-1]), NADPH oxidase activity, and O(2)(-) production were measured in normotensive rats with genetically high (Brown Norway [BN]) and low (Lewis) angiotensin-I-converting enzyme levels and in BN rats treated with the ROCK antagonist fasudil (100 mg/kg per day) for 7 days. ROCK activation was 12-fold higher in BN versus Lewis rats (P<0.05) and was reduced with fasudil by 100% (P<0.05). Aortic TGF-beta1, PAI-1, and monocyte chemoattractant protein-1 mRNA levels were higher in BN versus Lewis rats by 300%, 180%, and 1000%, respectively (P<0.05). Aortic TGF-beta1, PAI-1, and monocyte chemoattractant protein-1 protein levels were higher in BN versus Lewis rats (P<0,05). Fasudil reduced TGF-beta1 and PAI-1 mRNA and TGF-beta1, PAI-1, and monocyte chemoattractant protein-1 protein aortic levels to those observed in Lewis rats. Aortic reduced nicotinamide-adenine dinucleotide phosphate oxidase activity and ()O(2)(-) production were increased by 88% and 300%, respectively, in BN rats (P<0.05) and normalized by fasudil. In conclusion, ROCK is significantly activated in the aortic wall in normotensive rats with genetically high angiotensin-I-converting enzyme and angiotensin II, and it causes activation of genes that promote vascular remodeling and also increases vascular oxidative stress.
RhoA/Rho激酶(ROCK)信号通路是一种参与重塑和血管收缩的新机制。关于血管紧张素I转换酶水平升高而血压正常时ROCK激活的相关数据较少。我们推测,在血管紧张素I转换酶水平遗传性升高的正常血压大鼠的血管壁中,ROCK被激活,这会导致促进血管重塑的基因在血管中的表达增加,同时也会引发氧化应激。我们检测了血管紧张素I转换酶水平遗传性高(褐家鼠[BN])和低(刘易斯鼠)的正常血压大鼠以及用ROCK拮抗剂法舒地尔(每天100mg/kg)处理7天的BN大鼠的主动脉ROCK激活情况、mRNA和蛋白水平(单核细胞趋化蛋白-1、转化生长因子[TGF]-β1和纤溶酶原激活物抑制剂-1[PAI-1])、NADPH氧化酶活性以及超氧阴离子(O₂⁻)生成量。与刘易斯鼠相比,BN大鼠的ROCK激活水平高12倍(P<0.05),而法舒地尔可使其降低100%(P<0.05)。与刘易斯鼠相比,BN大鼠主动脉TGF-β1、PAI-1和单核细胞趋化蛋白-1的mRNA水平分别高出300%、180%和1000%(P<0.05)。与刘易斯鼠相比,BN大鼠主动脉TGF-β1、PAI-1和单核细胞趋化蛋白-1的蛋白水平更高(P<0.05)。法舒地尔可使TGF-β1和PAI-1的mRNA以及主动脉中TGF-β1、PAI-1和单核细胞趋化蛋白-1的蛋白水平降至刘易斯鼠的水平。与刘易斯鼠相比,BN大鼠主动脉还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶活性降低,超氧阴离子(O₂⁻)生成量分别增加88%和300%(P<0.05),而法舒地尔可使其恢复正常。总之,在血管紧张素I转换酶和血管紧张素II水平遗传性升高的正常血压大鼠的主动脉壁中,ROCK被显著激活,它会导致促进血管重塑的基因激活,并增加血管氧化应激。